C
Power Law company profile
Clementia Pharmaceuticals
Biotech & Life Sciences · Montreal, Canada · Founded 2012 · IPO 2017 Unicorn
Valuation
$1.31B
Market cap · 2026
Global footprint
Where Clementia Pharmaceuticals has talent and traffic
AI talent share
130.0%
of workforce is AI talent
(13 of 10 staff)
(13 of 10 staff)
Core AI330%
Other AI10100%
Non-AI workforce00%
Patent intelligence
$9M patent portfolio · 3 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$9M
0.70% of market cap · 773.3× smaller than top peer Janssen Vaccines ($7.1B)
3 active patent families
Where Clementia Pharmaceuticals innovates
PalovarotenePharmacologyEndocrinologyDosing regimenActivin receptor
Above peer median on Strategic, Market
Quality vs same-sector peers
Clementia Pharmaceuticals on the five Patsnap quality dimensions
Clementia Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Clementia Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Clementia Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Clementia Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.